Vimarsh Summit: India's Leap in Science and Biomedical Innovation

India's R&D sector is evolving significantly, driven by governmental support and strategic initiatives. The i3 Summit, inaugurated by Dr. Balram Bhargava, aims to fortify this progress by fostering collaboration among scientists and industry leaders. Blockchain For Impact (BFI) plays a pivotal role in strengthening India's healthcare innovation.


Devdiscourse News Desk | New Delhi | Updated: 25-07-2025 17:18 IST | Created: 25-07-2025 17:18 IST
Vimarsh Summit: India's Leap in Science and Biomedical Innovation
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.
  • Country:
  • India

India's research and development landscape is undergoing significant transformation, propelled by increased governmental focus and initiatives aimed at bolstering scientific and biomedical innovation ecosystems. Despite existing challenges in translating research to market and engaging the private sector consistently, the country's long-term commitment to R&D is unwavering.

The i3 Summit, known as Vimarsh, emerges as a key platform to advance these efforts. The event, inaugurated by Padma Shri Dr. Balram Bhargava and featuring Shri Nitin Gadkari as the Chief Guest, aims to empower scientists and entrepreneurs with opportunities for idea development and collaboration with industry leaders.

Notably, Sandeep Nailwal of Blockchain For Impact (BFI) has emphasized his dedication to fostering science and biomedical innovation in India. BFI, initially focused on enhancing healthcare systems during COVID-19, now redirects its efforts towards research and innovation, particularly through the BFI-BIOME Virtual Network Program to advance collaborations in the biomedical sector.

(With inputs from agencies.)

Give Feedback